Shares in Pulmatrix (NSDQ:PULM) rose slightly after the biotechnology company released its 3rd quarter results.
The Lexington, Mass.-based company reeled in its losses 35% to $3.2 million compared to a $4.9 million loss in Q3 last year. Revenue fell 91% compared with the same period last year to $61,000 for the 3 months ended September 30, 2016. Losses per share were -21¢.
Get the full story at our sister site, Drug Delivery Business News.
The post Pulmatrix reports Q3 loss, revenue down 91% appeared first on MassDevice.